Onyebuchi Ezigbo in Abuja The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the emergency use of AstraZeneca as COVID-19 vaccine in Nigeria. AstraZeneca, from India, is one of the two vaccines received by Nigeria and forwarded to NAFDAC for scientific study. The other one, Sputnik, developed by Russia, is still being studied by the agency. NAFDAC’s Director-General, Prof. Mojisola Adeyeye, at a press conference yesterday Abuja said the agency had evaluated the safety and efficacy of the vaccine for Nigerians. She said the vaccine could be stored in two to eight degrees Centigrade, adding that three more vaccines are being evaluated.